We keep an old look that we like Shell, but the national grid, they have a monopoly in the UK providing electricity. Revenue is a fairly certain and government plans to cap prices and cover the excess. Metronic is more of a medical device company. ABR, I mean, they're inviting diabetes a lot more. Both as an overview, both are a good option. We just bought share, I think, at an attractive price and maybe have some affinity towards them,. But we're still open to it. Yeah.
In this week's episode, we will share our thoughts about the dividend irrelevance theory. It's a challenge we often get as dividend growth investors from people around us, so we would like to clarify this. Hopefully once and for all!
Are you a fan of the show and would you like to show your support?
Then don't hesitate to buy European Dividend Growth Investor a Coffee. We are fundraising for his trip to Ireland so that we can meet face-2-face for the first time ever.
You can buy him a coffee via: https://www.buymeacoffee.com/edgi